Figure 4From: Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activatorScaffolds that have been utilized to develop arginino mimetic uPA inhibitors in the amidine (I-VI) and guanidine (VII-IX) series [12–16].Back to article page